A Randomized Trial of Two Surgical Techniques for Pancreaticojejunostomy in Patients Undergoing Pancreaticoduodenectomy

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2015 by Thomas Jefferson University
Information provided by (Responsible Party):
Thomas Jefferson University
ClinicalTrials.gov Identifier:
First received: August 1, 2006
Last updated: March 17, 2015
Last verified: March 2015
The purpose of this trial is to determine whether a mucosa-to-mucosa technique of pancreaticojejunostomy will improve the pancreatic fistula rate.

Condition Intervention
Pancreatic Neoplasms
Biliary Tract Neoplasms
Pancreatitis, Chronic
Duodenal Neoplasms
Procedure: pancreaticojejunostomy

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: A Randomized Trial of Two Surgical Techniques for Pancreaticojejunostomy in Patients Undergoing Pancreaticoduodenectomy

Resource links provided by NLM:

Further study details as provided by Thomas Jefferson University:

Primary Outcome Measures:
  • The primary endpoint will be the pancreatic fistula rate.

Secondary Outcome Measures:
  • length of hospitalization
  • percutaneous intervention rates
  • reoperation rates
  • morbidity
  • death

Study Start Date: July 2006
Estimated Study Completion Date: December 2015
Estimated Primary Completion Date: July 2015 (Final data collection date for primary outcome measure)
  Show Detailed Description


Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Patients must have undergone pancreaticoduodenectomy.
  • Must have pancreatic remnant remaining in place (body and tail).
  • Must be candidate for reconstruction by pancreaticojejunostomy by one of the two techniques described below.
  • Must have an identifiable pancreatic duct which can be used for a duct-to-mucosa anastomosis.

Exclusion Criteria:

  • Patients undergoing total pancreatectomy.
  • Patients undergoing PD who have had previous left-sided pancreatic resection.
  • Failure to sign informed consent.
  • Failure to identify the pancreatic duct.
  • Pregnant patients.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00359320

Contact: Adam C Berger, MD 215-955-1622 adam.berger@jefferson.edu

United States, Pennsylvania
Thomas Jefferson University Hospital Recruiting
Philadelphia, Pennsylvania, United States, 19107
Sub-Investigator: Charles Yeo, MD         
Sub-Investigator: Eugene P Kennedy, MD         
Sub-Investigator: Ernest Rosato, MD         
Sub-Investigator: Karen Chojnacki, MD         
Sub-Investigator: Cataldo Doria, MD         
Sub-Investigator: Bernadette Profeta, MD         
Sub-Investigator: Patricia Sauter, CRNP         
Sponsors and Collaborators
Thomas Jefferson University
Principal Investigator: Adam C Berger, MD Thomas Jefferson University
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Thomas Jefferson University
ClinicalTrials.gov Identifier: NCT00359320     History of Changes
Obsolete Identifiers: NCT00432848
Other Study ID Numbers: 06U.198 
Study First Received: August 1, 2006
Last Updated: March 17, 2015
Health Authority: United States: Institutional Review Board

Keywords provided by Thomas Jefferson University:
Pancreatic Cancer

Additional relevant MeSH terms:
Duodenal Diseases
Biliary Tract Neoplasms
Duodenal Neoplasms
Pancreatic Neoplasms
Pancreatitis, Chronic
Biliary Tract Diseases
Digestive System Diseases
Digestive System Neoplasms
Endocrine Gland Neoplasms
Endocrine System Diseases
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Intestinal Diseases
Intestinal Neoplasms
Neoplasms by Site
Pancreatic Diseases

ClinicalTrials.gov processed this record on May 25, 2016